These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 21450931)
21. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Borden LA; Murali Dhar TG; Smith KE; Weinshank RL; Branchek TA; Gluchowski C Eur J Pharmacol; 1994 Oct; 269(2):219-24. PubMed ID: 7851497 [TBL] [Abstract][Full Text] [Related]
22. A possible role of the non-GAT1 GABA transporters in transfer of GABA from GABAergic to glutamatergic neurons in mouse cerebellar neuronal cultures. Suñol C; Babot Z; Cristòfol R; Sonnewald U; Waagepetersen HS; Schousboe A Neurochem Res; 2010 Sep; 35(9):1384-90. PubMed ID: 20512624 [TBL] [Abstract][Full Text] [Related]
23. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro. Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317 [TBL] [Abstract][Full Text] [Related]
24. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. White HS Epilepsia; 1999; 40 Suppl 5():S2-10. PubMed ID: 10530688 [TBL] [Abstract][Full Text] [Related]
25. Basic mechanisms of gabitril (tiagabine) and future potential developments. Meldrum BS; Chapman AG Epilepsia; 1999; 40 Suppl 9():S2-6. PubMed ID: 10612355 [TBL] [Abstract][Full Text] [Related]
26. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. Smith SE; Parvez NS; Chapman AG; Meldrum BS Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333 [TBL] [Abstract][Full Text] [Related]
27. Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues. Clausen RP; Moltzen EK; Perregaard J; Lenz SM; Sanchez C; Falch E; Frølund B; Bolvig T; Sarup A; Larsson OM; Schousboe A; Krogsgaard-Larsen P Bioorg Med Chem; 2005 Feb; 13(3):895-908. PubMed ID: 15653355 [TBL] [Abstract][Full Text] [Related]
28. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100 [TBL] [Abstract][Full Text] [Related]
29. Inhibitory nature of tiagabine-augmented GABAA receptor-mediated depolarizing responses in hippocampal pyramidal cells. Jackson MF; Esplin B; Capek R J Neurophysiol; 1999 Mar; 81(3):1192-8. PubMed ID: 10085346 [TBL] [Abstract][Full Text] [Related]
30. Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition. Schmitt U; Lüddens H; Hiemke C Pharmacol Biochem Behav; 2000 Feb; 65(2):351-6. PubMed ID: 10672990 [TBL] [Abstract][Full Text] [Related]
31. Extrasynaptic GABAA receptors in rat pontine reticular formation increase wakefulness. Vanini G; Baghdoyan HA Sleep; 2013 Mar; 36(3):337-43. PubMed ID: 23450652 [TBL] [Abstract][Full Text] [Related]
32. Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA. Stahl SM J Clin Psychiatry; 2004 Mar; 65(3):291-2. PubMed ID: 15096065 [No Abstract] [Full Text] [Related]
33. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs. Eckstein-Ludwig U; Fei J; Schwarz W Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839 [TBL] [Abstract][Full Text] [Related]
34. Anticonvulsant activity of the gamma-aminobutyric acid uptake inhibitor N-4,4-diphenyl-3-butenyl-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol . White HS; Hunt J; Wolf HH; Swinyard EA; Falch E; Krogsgaard-Larsen P; Schousboe A Eur J Pharmacol; 1993 May; 236(1):147-9. PubMed ID: 8319739 [TBL] [Abstract][Full Text] [Related]
35. Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam. Chuang SH; Reddy DS J Pharmacol Exp Ther; 2020 Mar; 372(3):285-298. PubMed ID: 31843812 [TBL] [Abstract][Full Text] [Related]
36. Effects of chronic tiagabine treatment on [3H]GABAA, [3H]GABAB and [3H]tiagabine binding to sections from mice brain. Thomsen C; Suzdak PD Epilepsy Res; 1995 Jun; 21(2):79-88. PubMed ID: 7588591 [TBL] [Abstract][Full Text] [Related]
37. Selective suppression of hippocampal region hyperexcitability related to seizure susceptibility in epileptic El mice by the GABA-transporter inhibitor tiagabine. Fueta Y; Schwarz W; Ohno K; Endo Y; Mita T Brain Res; 2002 Aug; 947(2):212-7. PubMed ID: 12176163 [TBL] [Abstract][Full Text] [Related]
38. Delineation of the Role of Astroglial GABA Transporters in Seizure Control. Schousboe A; Madsen KK Neurochem Res; 2017 Jul; 42(7):2019-2023. PubMed ID: 28190226 [TBL] [Abstract][Full Text] [Related]
39. Anticonvulsant activity of intracerebroventricularly administered glial GABA uptake inhibitors and other GABAmimetics in chemical seizure models. Gonsalves SF; Twitchell B; Harbaugh RE; Krogsgaard-Larsen P; Schousboe A Epilepsy Res; 1989; 4(1):34-41. PubMed ID: 2526732 [TBL] [Abstract][Full Text] [Related]
40. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Nielsen EB; Suzdak PD; Andersen KE; Knutsen LJ; Sonnewald U; Braestrup C Eur J Pharmacol; 1991 Apr; 196(3):257-66. PubMed ID: 1832636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]